missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Reagenzien für die Proteinanalyse
  4. Bioaktive kleine Moleküle
  5. Tocris Bioscience™ Selinexor

Tocris Bioscience™ Selinexor
GREENER_CHOICE

Artikelnummer. 18737176
Click to view available options
Menge:
10 mg
50 mg
Packungsgröße:
10 Milligramm
50 Milligramm
Dieser Artikel kann nicht zurückgegeben werden. Rückgaberichtlinie anzeigen

Product Code. 18737176

Brand: Tocris Bioscience™ 7760/10

Bitte Sie sich an, um diesen Artikel zu kaufen. Sie benötigen ein Web-Konto? Registrieren Sie sich noch heute!

This item is not returnable. View return policy

Description

Selective exportin 1 (XPO1/CRM1) inhibitor

Selinexor is an inhibitor of the exportin 1 (XPO1/CRM1) nuclear exporter. Shows selectivity for TNBC over ER-positive breast cancer cell lines (IC50 values are 11-550 nM and >1000 nM, respectively), and reduces growth of xenografts. Inhibits growth of thyroid cancer cell lines (IC50 = 150-500 nM), potentiates the anti-tumor effects of Olaparib (Cat. No. 7579) in ovarian cancer and breast cancer. Also a potent inhibitor of SARS-CoV-2 replication in vitro (EC50 = 10 nM) and downregulates the production of pro-inflammatory cytokines including TNF-α and IL-6.
TRUSTED_SUSTAINABILITY

Specifications

Chemischer Name oder Material (2Z)-3-[3-[3,5-Bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl]-2-propenoic acid 2-(2-pyrazinyl)hydrazide
CAS 1393477-72-9
Menge 10 mg
Ziel Antiviral Compounds
Summenformel C17H11F6N7O
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.